Clinical assessment and current treatment of refractory chronic cough
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
Review Article
World Journal of Advanced Research and Reviews, 2023, 18(03), 1469–1476
Article DOI: 10.30574/wjarr.2023.18.3.1264
Publication history:
Received on 21 May 2023; revised on 28 June 2023; accepted on 30 June 2023
Abstract:
Chronic cough is a cough that occurs for more than 2 months. Chronic cough is a health problem that can cause physical complications, psychology problem, dan impact on quality of life. The common causes of chronic cough are asthma, eosinophilic bronchitis, gastroesophageal reflux disease, angiotensin-converting enzyme inhibitor use, smoking, and upper airway cough syndrome. Refractory chronic cough is a cough that is persistent after optimal therapy of underlying diseases. Recent theory regarding the neural system contributes to the pathophysiology of refractory chronic cough known as cough hypersensitivity syndrome. Treatment of refractory chronic cough needs comprehensive evaluation of cough severity, trigger of cough, and underlying diseases. Neuromodulators can be used as pharmacology treatment of refractory chronic cough but still need more research to define standard dose and safety.
Keywords:
Chronic Cough; Cough Hypersensitivity Syndrome; Cough Assessment; Neuromodulator
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0